Oncology
Gynecologic Cancer
2
Pipeline Programs↗
10
Active Trials↗
5
Companies Involved↗
Gynecologic Cancer is an early-stage landscape with 2 programs across 5 companies. The most active players are Teva, Azurity Pharmaceuticals, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Approved
No programs
Analysis
Modality Breakdown
2programs
Small molecule150%
Protein / enzyme150%
Modality classified for 100% of 2 pipeline programs.
Analysis
Trial Status
21
clinical trials
Recruiting8 · 38%
Completed7 · 33%
Not yet recruiting2 · 10%
Unknown status2 · 10%
Withdrawn1 · 5%
Terminated1 · 5%
Clinical Trials
Trial Activity
21 trials
Phase II Clinical Trial of Cesium-131 Low-dose Rate Interstitial Brachytherapy as an Organ-preserving Irradiation Technique for Recurrent Cervical and Endometrial Cancer
Recruiting·—·Preclinical·NCT07631572·10 enrolled
The Impact of Massage Therapy on Pain and Anxiety of Patients With Gynecologic Cancer While Receiving Infusion Treatment (IMPACT)
Not yet recruiting·—·Preclinical·NCT07502157·24 enrolled
Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer
Completed·—·N/A·NCT01679483·40 enrolled
Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy
Completed·—·Phase 3·NCT01435200·64 enrolled
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery
Completed·—·Phase 1·NCT00842452·26 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)